Related Experiment Video
Updated: Jan 9, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches - systematic review
Muhammad Bari Hassan1, Sadia Siddique, Sandeep Kumar Maheshwari
1Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
Insights
Chronic kidney disease (CKD) significantly elevates cardiovascular disease (CVD) risk, leading to higher event rates and mortality. Early detection and management of CKD and its associated risk factors are crucial for patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Chronic kidney disease (CKD) is a significant public health issue.
- CKD is strongly associated with increased cardiovascular risk, events, and mortality, particularly in moderate to severe stages.
- Understanding the CKD-CVD relationship is vital for patient management.
Purpose of the Study:
- To systematically review the relationship between CKD and cardiovascular risk.
- To explore the pathophysiology, risk factors, and clinical outcomes of cardiovascular disease (CVD) in CKD populations.
Main Methods:
- A comprehensive literature search was performed across electronic databases.
- Seven studies (cross-sectional, cohort) with 104,576 participants were included.
- Data on renal dysfunction, cardiovascular risk factors, and mortality were extracted and analyzed.
Main Results:
- CKD is consistently linked to a higher risk of cardiovascular events (e.g., coronary heart disease, stroke) compared to non-CKD individuals.
- Even early CKD stages show increased CVD likelihood.
- CKD patients have a greater prevalence of traditional CVD risk factors and a significantly higher cardiovascular mortality rate.
Conclusions:
- CKD is a strong predictor of increased cardiovascular morbidity and mortality.
- Higher stages of renal dysfunction correlate with greater cardiovascular risk.
- Early detection and comprehensive management of cardiovascular risk factors in CKD patients are essential, necessitating further research into novel biomarkers and therapies.
Background:
Chronic kidney disease (CKD) is a major public health concern due to its association with increased cardiovascular risk. Patients with CKD, especially those with moderate to severe renal dysfunction, face a heightened risk of cardiovascular events and mortality. This systematic review evaluates the relationship between CKD and cardiovascular risk, focusing on the pathophysiology, risk factors, and clinical outcomes related to cardiovascular disease (CVD) in CKD populations.
Methods:
A comprehensive search of electronic databases was conducted for studies investigating CKD and cardiovascular risk. Seven studies, including cross-sectional, and cohort designs, were included in this review. These studies involved a total of 104,576 participants, with diverse stages of CKD and varying cardiovascular risk profiles. Data on renal dysfunction stages, cardiovascular risk factors, and mortality outcomes were extracted and analyzed.
Results:
The studies consistently demonstrated that CKD is associated with an increased risk of cardiovascular events, including coronary heart disease and stroke, compared to individuals without CKD. Even early stages of CKD were linked to a higher likelihood of CVD. Participants with CKD exhibited a greater burden of traditional cardiovascular risk factors, including hypertension, diabetes, dyslipidemia, and obesity. The overall mortality rate from cardiovascular causes was also higher in CKD patients, with some studies reporting a two-fold or greater increase in risk.
Conclusion:
CKD is strongly linked to an increased cardiovascular risk, with higher stages of renal dysfunction associated with a more significant risk of cardiovascular morbidity and mortality. This review emphasizes the need for early detection and comprehensive management of cardiovascular risk factors in CKD patients. Future research should focus on identifying novel biomarkers and evaluating the long-term efficacy of emerging therapies in reducing cardiovascular risk in CKD populations.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
01:25Chronic Kidney Disease I: Introduction
01:18Chronic Kidney Disease IV: Nursing Management
01:24Chronic Kidney Disease II: Clinical Manifestations
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:30Coronary Artery Disease I: Introduction